Jeffrey Berkowitz's Insider Trades & SAST Disclosures

Jeffrey Berkowitz's most recent trade in Esperion Therapeutics Inc. was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 26, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Esperion Therapeutics Inc.
Jeffrey Berkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 20,000 20,000 - - Stock Option (right to buy)
Esperion Therapeutics Inc.
Jeffrey Berkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2021 12,376 23,449 (0%) 0% 0 Common Stock
Esperion Therapeutics Inc.
Jeffrey Berkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 6,106 11,073 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades